B Pasini

Summary

Affiliation: University of Turin
Country: Italy

Publications

  1. pmc Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
    Anna Marie Mulligan
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK
    Breast Cancer Res 13:R110. 2011
  2. pmc Exploring the link between MORF4L1 and risk of breast cancer
    Griselda Martrat
    Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research IDIBELL, Gran Via 199, L Hospitalet del Llobregat 08908, Spain
    Breast Cancer Res 13:R40. 2011
  3. pmc Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma
    Jean Pierre Bayley
    Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
    BMC Med Genet 7:1. 2006
  4. pmc SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes
    B Pasini
    Department of Genetics, Biology and Biochemistry, University of Turin, Via Santena 19, Turin 10126, Italy
    J Intern Med 266:19-42. 2009
  5. ncbi request reprint Evaluating breast cancer risk: available models to assess individual breast cancer risk and probability to be a BRCA mutation carrier
    B Pasini
    Dipartimento di Genetica, Biologia e Biochimica, Universita di Torino, Torino, Italy
    J Exp Clin Cancer Res 21:23-9. 2002
  6. ncbi request reprint The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk
    F Podo
    Istituto Superiore di Sanita, Laboratorio di Biologia Cellulare, Roma, Italy
    J Exp Clin Cancer Res 21:115-24. 2002
  7. ncbi request reprint BMRI in early detection of breast cancer in patients with increased genetic risk: our preliminary results
    G Trecate
    Unit of Diagnostic Radiology A, Istituto Nazionale Tumori, Milan, Italy
    J Exp Clin Cancer Res 21:125-30. 2002
  8. pmc Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies
    A Antoniou
    Cancer Research U K Genetic Epidemiology Unit, Department of Public Health, University of Cambridge, Cambridge, United Kingdom
    Am J Hum Genet 72:1117-30. 2003
  9. pmc Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies
    A C Antoniou
    J Med Genet 42:602-3. 2005
  10. pmc Association of a new cationic trypsinogen gene mutation (V39A) with chronic pancreatitis in an Italian family
    C Arduino
    Gut 54:1663-4. 2005

Collaborators

  • C A Stratakis
  • Antonis C Antoniou
  • C Zuiani
  • F Podo
  • J Gronwald
  • Julian Peto
  • K Heimdal
  • H Nevanlinna
  • H Eerola
  • Steven Narod
  • F Sardanelli
  • J L Hopper
  • Mark E Robson
  • Caryn E Lerman
  • Håkan L Olsson
  • A Brusco
  • H A Risch
  • N Loman
  • Bernard Peissel
  • Marie Stenmark-Askmalm
  • Ramunas Janavicius
  • Daniela Zaffaroni
  • Katherine L Nathanson
  • Susan Peock
  • Paolo Radice
  • Zachary Fredericksen
  • Mary B Daly
  • Georgia Chenevix-Trench
  • Lesley McGuffog
  • Alessandra Viel
  • Jackie Cook
  • Siranoush Manoukian
  • Isabelle Mortemousque
  • Fiona Lalloo
  • D Gareth Evans
  • Conxi Lazaro
  • Sylvie Mazoyer
  • Louise Izatt
  • Sue Healey
  • Ignacio Blanco
  • Ana Osorio
  • Susan M Domchek
  • Tuomas Heikkinen
  • Esther M John
  • Dominique Stoppa-Lyonnet
  • Fergus J Couch
  • Debra Frost
  • Anna Marie Mulligan
  • Hanne E J Meijers-Heijboer
  • Antonella Savarese
  • Trinidad Caldes
  • Loris Bernard
  • Ute Hamann
  • Griselda Martrat
  • Laura Ottini
  • Paolo Peterlongo
  • Xianshu Wang
  • Rosemarie Davidson
  • Douglas F Easton
  • Olga M Sinilnikova
  • Andrew K Godwin
  • Javier Benitez
  • Jean Pierre Bayley
  • P Mandich
  • C Arduino
  • G Trecate
  • G Della Torre
  • Melissa Southey
  • Xiaoqing Chen
  • Kaoru Tominaga
  • Evgeny N Imyanitov
  • Pascal Pujol
  • Encarna B Gomez Garcia
  • Matti Rookus
  • Jean Philippe Peyrat
  • Oskar Thor Johannsson
  • Fiona Douglas
  • Christian F Singer
  • Rosa B Barkardottir
  • Patricia A Ganz
  • Anneliese Fink-Retter
  • Amanda E Toland
  • Dorothea Gadzicki
  • Kirsten B Moysich
  • Danielle Bodmer
  • Marie Agnès Collonge-Rame
  • Noralane M Lindor
  • Roni Milgrom
  • Britta Fiebig
  • Daphne Gschwantler-Kaulich

Detail Information

Publications14

  1. pmc Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
    Anna Marie Mulligan
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK
    Breast Cancer Res 13:R110. 2011
    ..It is currently unknown how these alleles are associated with different breast cancer subtypes in BRCA1 and BRCA2 mutation carriers defined by estrogen (ER) or progesterone receptor (PR) status of the tumour...
  2. pmc Exploring the link between MORF4L1 and risk of breast cancer
    Griselda Martrat
    Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research IDIBELL, Gran Via 199, L Hospitalet del Llobregat 08908, Spain
    Breast Cancer Res 13:R40. 2011
    ..To gain deeper insight into this pathway and its influence on cancer risk, we searched for novel components through protein physical interaction screens...
  3. pmc Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma
    Jean Pierre Bayley
    Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
    BMC Med Genet 7:1. 2006
    ..Succinate dehydrogenase is a heterotetrameric protein complex and a component of both the Krebs cycle and the mitochondrial respiratory chain (succinate:ubiquinone oxidoreductase or complex II)...
  4. pmc SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes
    B Pasini
    Department of Genetics, Biology and Biochemistry, University of Turin, Via Santena 19, Turin 10126, Italy
    J Intern Med 266:19-42. 2009
    ....
  5. ncbi request reprint Evaluating breast cancer risk: available models to assess individual breast cancer risk and probability to be a BRCA mutation carrier
    B Pasini
    Dipartimento di Genetica, Biologia e Biochimica, Universita di Torino, Torino, Italy
    J Exp Clin Cancer Res 21:23-9. 2002
    ..Aim of this work is to underline validity and limits of available tools and their appropriate use in the daily practice...
  6. ncbi request reprint The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk
    F Podo
    Istituto Superiore di Sanita, Laboratorio di Biologia Cellulare, Roma, Italy
    J Exp Clin Cancer Res 21:115-24. 2002
    ..These preliminary results confirmed that MRI is a very useful tool to screen subjects at high genetic risk for breast carcinoma, not only in pre-, but also in post-menopausal age, with a low probability of false positive cases...
  7. ncbi request reprint BMRI in early detection of breast cancer in patients with increased genetic risk: our preliminary results
    G Trecate
    Unit of Diagnostic Radiology A, Istituto Nazionale Tumori, Milan, Italy
    J Exp Clin Cancer Res 21:125-30. 2002
    ..High spatial resolution and no breast density influence can give more detailed information about smaller lesions and the right extent of the disease...
  8. pmc Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies
    A Antoniou
    Cancer Research U K Genetic Epidemiology Unit, Department of Public Health, University of Cambridge, Cambridge, United Kingdom
    Am J Hum Genet 72:1117-30. 2003
    ..The variation in risk by age at diagnosis of index case is consistent with the effects of other genes modifying cancer risk in carriers...
  9. pmc Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies
    A C Antoniou
    J Med Genet 42:602-3. 2005
    ..These estimates appear to be consistent with the observed prevalence of the mutations in the Ashkenazi Jewish population...
  10. pmc Association of a new cationic trypsinogen gene mutation (V39A) with chronic pancreatitis in an Italian family
    C Arduino
    Gut 54:1663-4. 2005
  11. ncbi request reprint Cancer genetic counselling
    P Mandich
    Ann Oncol 16:171. 2005
  12. pmc CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation
    G Della Torre
    Department of Experimental Oncology, Istituto Nazionale Tumori, Via Venezian, 1 20133 Milan, Italy
    Br J Cancer 85:836-44. 2001
    ..In addition, they indicate the need for a combination of functional assays to determine the pathogenetic nature of new CDKN2A mutations...
  13. ncbi request reprint Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group
    S A Narod
    Centre for Research on Women s Health, Women s College Hospital, University of Toronto, Ontario, Canada
    Lancet 356:1876-81. 2000
    ..Tamoxifen protects against contralateral breast cancer in the general population, but whether it protects against contralateral breast cancer in BRCA1 or BRCA2 mutation carriers is not known...
  14. ncbi request reprint Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease
    G Romeo
    Istituto Giannina Gaslini, Genova Quarto, Italy
    Nature 367:377-8. 1994
    ..Our results support the hypothesis that RET, in addition to its potential role in tumorigenesis, plays a critical role in the embryogenesis of the mammalian enteric nervous system...